Journal article · 2026 · Open access

Nicotinamide suppresses cytosolic DNA-Driven immunity independent of NAD+ via epigenetic modulation

Yanyan Shen, Yanhong Liu, Yue Guo, Jiayu Liu, Boyang Xie, Qi Qi, Yao Wang, Ruibo Wang, Chunyan Yan, Zhi Jin, Aiping Cao, Juncheng Li and 8 more

Cell Communication and Signaling · Published 14 September 2026 · DOI 10.1186/s12964-026-03195-2

Open full textCite this paper

In brief

“Nicotinamide suppresses cytosolic DNA-Driven immunity independent of NAD+ via epigenetic modulation” is a 2026 journal article by Yanyan Shen and 19 co-authors, published in Cell Communication and Signaling. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at Cell Communication and Signaling.

Citations
0
Authors
20

Abstract

Dysregulation of cytosolic DNA-triggered IFN-I signaling is a key driver of autoimmune and autoinflammatory pathogenesis. Precise metabolic orchestration of cytokine signaling is critical for immune homeostasis, but the role of endogenous metabolites in fine-tuning IFN-I transcriptional output remains elusive. Here, we identify nicotinamide (NAM), a traditional NAD + precursor, as an immunosuppressor that dynamically accumulates upon cytosolic DNA stimulation and restrains IFN-I signaling independently of NAD + . Further study demonstrates that cytosolic DNA sensing specifically upregulates the NAD + hydrolase CD38, which mediates NAM accumulation through hydrolyzing NAD + . Mechanistic investigations reveal that NAM reduces the activating histone mark H3K4me3 at the IFNB promoter, thereby decreasing chromatin accessibility, impairing IRF3 recruitment, and ultimately suppressing IFNB transcription. Importantly, in vivo NAM administration dampens aberrant IFN-I signatures and alleviates autoimmune pathology in Trex1 ⁻/⁻ mice (a well-established model of IFN-I-driven autoimmunity). Collectively, our study uncovers a novel immunomodulatory function of NAM that is free from NAD + synthesis, delineates its epigenetic regulatory cascade on IFN-I signaling, and proposes the CD38-NAM axis as a therapeutic target for IFN-I-associated diseases.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Shen, Y., Liu, Y., Guo, Y., Liu, J., Xie, B., Qi, Q., Wang, Y., Wang, R., Yan, C., Jin, Z., Cao, A., Li, J., Han, Q., Chen, L., Pan, X., Zhang, X., Zhou, T., Li, A., Xia, Q., & Zhang, W. (2026). Nicotinamide suppresses cytosolic DNA-Driven immunity independent of NAD+ via epigenetic modulation. Cell Communication and Signaling. https://doi.org/10.1186/s12964-026-03195-2

MLA 9

Shen, Yanyan, et al. “Nicotinamide suppresses cytosolic DNA-Driven immunity independent of NAD+ via epigenetic modulation.” Cell Communication and Signaling, 2026. https://doi.org/10.1186/s12964-026-03195-2.

Chicago

Shen, Yanyan, Yanhong Liu, Yue Guo, Jiayu Liu, Boyang Xie, Qi Qi, Yao Wang, et al. 2026. “Nicotinamide suppresses cytosolic DNA-Driven immunity independent of NAD+ via epigenetic modulation.” Cell Communication and Signaling. https://doi.org/10.1186/s12964-026-03195-2.

Harvard

Shen, Y. et al. (2026) ‘Nicotinamide suppresses cytosolic DNA-Driven immunity independent of NAD+ via epigenetic modulation’, Cell Communication and Signaling. doi:10.1186/s12964-026-03195-2.

IEEE

Y. Shen et al., “Nicotinamide suppresses cytosolic DNA-Driven immunity independent of NAD+ via epigenetic modulation,” Cell Communication and Signaling, 2026, doi: 10.1186/s12964-026-03195-2.

BibTeX

@article{shen2026nicotinamide,
  title     = {{Nicotinamide suppresses cytosolic DNA-Driven immunity independent of NAD+ via epigenetic modulation}},
  author    = {Shen, Yanyan and Liu, Yanhong and Guo, Yue and Liu, Jiayu and Xie, Boyang and Qi, Qi and Wang, Yao and Wang, Ruibo and Yan, Chunyan and Jin, Zhi and Cao, Aiping and Li, Juncheng and Han, Qiuying and Chen, Liang and Pan, Xin and Zhang, Xuemin and Zhou, Tao and Li, Ailing and Xia, Qing and Zhang, Weina},
  journal   = {Cell Communication and Signaling},
  year      = {2026},
  doi       = {10.1186/s12964-026-03195-2},
  url       = {https://doi.org/10.1186/s12964-026-03195-2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses

  • nicotinamide
  • cytosolic DNA sensing
  • CD38
  • NAD+ hydrolase
  • H3K4me3
  • chromatin accessibility
  • IRF3
  • epigenetic regulation

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Shen, Y., Liu, Y., Guo, Y., Liu, J., Xie, B., Qi, Q., Wang, Y., Wang, R., Yan, C., Jin, Z., Cao, A., Li, J., Han, Q., Chen, L., Pan, X., Zhang, X., Zhou, T., Li, A., Xia, Q., & Zhang, W. (2026). Nicotinamide suppresses cytosolic DNA-Driven immunity independent of NAD+ via epigenetic modulation. Cell Communication and Signaling. https://doi.org/10.1186/s12964-026-03195-2

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cell Communication and Signaling: sign in and open the full text from this page.

Who wrote this paper?

Yanyan Shen, Yanhong Liu, Yue Guo, Jiayu Liu, Boyang Xie, Qi Qi, Yao Wang, Ruibo Wang, Chunyan Yan, Zhi Jin, Aiping Cao, Juncheng Li and 8 more.

What is the DOI of this paper?

10.1186/s12964-026-03195-2, permanently at https://doi.org/10.1186/s12964-026-03195-2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.